Explore By Subject Area   
Return Home
Menu

Lead Podcast

How PALADIN Consortium Aims to Enhance Efficient Patient Advocacy-Industry Collaborations

How PALADIN Consortium Aims to Enhance Efficient Patient Advocacy-Industry Collaborations

This podcast covers how the pre-competitive group is creating resources designed to make industry-patient advocacy collaborations more effective without having to reinvent the wheel.

Read More

Featured Podcasts

Partnering with Patients in Clinical Development Using the Biopsychosocial Model

Sponsored

Read More

How Montefiore Gets Early Stage Clinical Trials to Under-Resourced Communities

Read More

How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development

Read More

Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials

Read More

More Related Content

Pharmatalk Radio Podcasts

What to Expect at the 2025 Patients as Partners EU Conference

What to Expect at the 2025 Patients as Partners EU Conference
Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design

Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care

Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
The Personal Impact of a Clinical Trial

The Personal Impact of a Clinical Trial
The Future of Patient-Centricity: Advancing Frameworks to Achieve Greater Impact for Patients

The Future of Patient-Centricity: Advancing Frameworks to Achieve Greater Impact for Patients
Astellas’ Head of Patient Centricity on his New Book "A Bandana and a Bluebird," and Lessons from Patients for Medicine Development

Astellas’ Head of Patient Centricity on his New Book "A Bandana and a Bluebird," and Lessons from Patients for Medicine Development
Patient Engagement Advocate on Collaborating Successfully with Pharma

Patient Engagement Advocate on Collaborating Successfully with Pharma

Sponsored
Strategies for Enhancing Clinical Trial Participation from Diverse Linguistic Backgrounds

Strategies for Enhancing Clinical Trial Participation from Diverse Linguistic Backgrounds
Using Sustainability to Empower Patient Engagement Goals in Medicine Development

Using Sustainability to Empower Patient Engagement Goals in Medicine Development
Optimizing the Integration of Mobile, Patient-Facing Technologies in Clinical Trials for Accessibility and Flexibility

Optimizing the Integration of Mobile, Patient-Facing Technologies in Clinical Trials for Accessibility and Flexibility
Delivering Exceptional Clinical Trial Experiences for Patients

Delivering Exceptional Clinical Trial Experiences for Patients
What to Expect at the 2024 Patients as Partners EU Conference

What to Expect at the 2024 Patients as Partners EU Conference
Turning Her Search for Lung Cancer Biomarkers into a Patient Empowerment Community

Turning Her Search for Lung Cancer Biomarkers into a Patient Empowerment Community
Engaging Internal Stakeholders to Embed Patient Engagement in a Meaningful Way that Drives Value for All

Engaging Internal Stakeholders to Embed Patient Engagement in a Meaningful Way that Drives Value for All
Optimizing Medicine Development for Real-World Efficacy in Patients: A Biopsychosocial Approach

Optimizing Medicine Development for Real-World Efficacy in Patients: A Biopsychosocial Approach

Sponsored
Patients on How R&D Organizations Can Better Operationalize Trials for Patients

Patients on How R&D Organizations Can Better Operationalize Trials for Patients
Community Organization Perspectives on Improving Clinical Trial Initiatives

Community Organization Perspectives on Improving Clinical Trial Initiatives
How Merck is Successfully Partnering with Communities: Case Example

How Merck is Successfully Partnering with Communities: Case Example
How Janssen is Collaborating with Patients and Sites to Advance DCTs

How Janssen is Collaborating with Patients and Sites to Advance DCTs
Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic

Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic
Sanofi's New Initiatives Embed Patient Voices and Priorities from Discovery to Patient Access

Sanofi's New Initiatives Embed Patient Voices and Priorities from Discovery to Patient Access
Legal Barriers to Patient Involvement and Potential Pathways to Overcome Them

Legal Barriers to Patient Involvement and Potential Pathways to Overcome Them
Adjusting Your eCOA Strategy For Patient Centricity: Expert Advice

Adjusting Your eCOA Strategy For Patient Centricity: Expert Advice

Sponsored
The Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity

The Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity

Sponsored
How to Utilize Technology to Truly Increase Diversity in Clinical Trials

How to Utilize Technology to Truly Increase Diversity in Clinical Trials

Sponsored

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.